Hb-022 Inc

Hb-022 improves drug bioavailability using proprietary formulations to enhance systemic exposure. The approach combines licensed formulations technology, proprietary excipients, and AI-driven strategies to accelerate clinical development. Hb-022 partners with accredited manufacturers and pharma companies to license its technology and support faster IND, Phase I and II timelines. The company targets pharma partners and investors, highlighting capital efficiency and real-time pipeline valuation via an AI platform.

AIBioavailabilityBiotechClinical DevelopmentCommercializationDrug DevelopmentFormulationsLicensinghb-022.com

Hb-022 Inc

AIBioavailabilityBiotechClinical DevelopmentCommercializationDrug DevelopmentFormulationsLicensinghb-022.com

HQAustin, US

Team Size2

Open Jobs1

Total Funding-

Latest FundraiseUnknown

Join the Team

Teeming tracks opportunities at over 24,000 AI startups, then works with you to find (and land) the one you'll love.

Backend Developer

Part-timeAmsterdam, NL

Part-time • Amsterdam, NL

Backend Developer

InternshipNiš, RS

Internship • Niš, RS

Data Scientist

ContractMunich, DE

Contract • Munich, DE

Backend Developer

Part-timeHamburg, DE

Part-time • Hamburg, DE

Machine Learning Engineer

Full-timeBerlin, DE

Full-time • Berlin, DE

AI Researcher

InternshipAustin, US

Internship • Austin, US